Roxbury Financial’s Tema Oncology ETF CANC Stock Holding History

Roxbury Financial’s Portfolio CANC Stock Details CANC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$162K	Buy	3,940 +3,016	+326%	+$114K	0.13%	114
2026 Q1	$33.9K	Buy	+924	New	+$33.6K	0.03%	215

Roxbury Financial's CANC Position: Q2 2026 in Review

Roxbury Financial increased its Tema Oncology ETF (CANC) stake by 326% in Q2 2026, buying an estimated $114K and bringing the position to 3,940 shares worth $162K. The position accounts for 0.13% of the portfolio, ranked #114.

Roxbury Financial first reported a position in CANC in Q1 2026 and has held it in 2 quarters since. 1 fund tracked by Wall St. Rank holds CANC as of Q2 2026.

Roxbury Financial held 3,940 shares of Tema Oncology ETF worth $162K as of Q2 2026.
Roxbury Financial bought 3,016 Tema Oncology ETF shares in Q2 2026, an estimated $114K.
Tema Oncology ETF made up 0.13% of Roxbury Financial's portfolio in Q2 2026, its #114 holding.
Roxbury Financial first reported a position in Tema Oncology ETF in Q1 2026 and has held it in 2 quarters since.
1 fund tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.